Shokrollah Elahi led new research that sheds light on why many COVID-19 patients have low levels of oxygen in their blood, and why the anti-inflammatory drug dexamethasone works to treat the potentially dangerous condition. (Photo: Faculty of Medicine & Dentistry)

New study may help explain low oxygen levels in COVID-19 patients

Posted on

U of A researchers find SARS-CoV-2 infects immature red blood cells, reducing oxygen in the blood and impairing immune response.

A new study published in the journal Stem Cell Reports by University of Alberta researchers is shedding light on why many COVID-19 patients, even those not in hospital, are suffering from hypoxia—a potentially dangerous condition in which there is decreased oxygenation in the body’s tissues. The study also shows why the anti-inflammatory drug dexamethasone has been an effective treatment for those with the virus….

https://www.ualberta.ca/folio/2021/06/new-study-may-help-explain-low-oxygen-levels-in-covid-19-patients.html

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]